Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol. 2020;26(1):60-69.   Published online 2019 Oct 22     DOI:
Citations to this article as recorded by Crossref logo
Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia
Nikola Kokanov, Snezana Jovanovic-Cupic, Marina Siljic, Valentina Cirkovic, Nina Petrovic, Bojana Kozik, Milena Krajnovic
Archives of Biological Sciences.2023; 75(3): 251.     CrossRef
RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin
Nikola Kokanov, Milena Krajnovic, Snezana Cupic-Jovanovic, Bojana Kozik, Nina Petrovic, Ana Bozovic, Vesna Mandusic
Archives of Biological Sciences.2022; 74(1): 57.     CrossRef
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea
Jae Seung Lee, Hong Jun Choi, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2021; 36(9): 2479.     CrossRef
A longitudinal sampling study of transcriptomic and epigenetic profiles in patients with thrombocytopenia syndrome
Yafen Wang, Shaoqing Han, Ruoxi Ran, Anling Li, Huanyu Liu, Mingjun Liu, Yongwei Duan, Xiong Zhang, Zhigang Zhao, Shihui Song, Xiaocheng Weng, Song-Mei Liu, Xiang Zhou
Nature Communications.2021;[Epub]     CrossRef